Use of ACE inhibitors (OR 0.93 95% CI 0.91–0.94; OR 0.88; 95% CI 0.86–0.90), angiotensin II blockers (OR 0.87 95% CI 0.86–0.89; OR 0.84 95% CI 0.81–0.86), and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (OR 0.89 95% CI 0.87–0.91; OR 0.87 95% CI 0.84–0.92) were modestly associated with lower rates of COVID-19-related hospitalization or death, respectively. Here, ACE is linked to COVID-19.